openPR Logo
Press release

Bone Glue Market Industry Forecast till 2024

08-16-2018 01:56 PM CET | Health & Medicine

Press release from: Coherent Market Insights

Osteoporosis is a common cause for bone fractures and its prevalence gradually increases with age. For instance, the prevalence ratio of osteoporosis increase from 5% at 50 years to 50% at 85 years among women. According to the National Osteoporosis Foundation, there were 7-8 million females aged over 50 years suffering from osteoporosis and 21.8 million suffering from osteopenia in the U.S., in 2002. It further states that the number of bone fractures will increase by 2 to 4 times by 2020 and 41 million women will suffering from osteoporosis or osteopenia. This is mainly attributed to significant rise in the aging population. In 2002, 12–17% of the population in Europe were aged over 65, which is expected to increase to 20–25% by 2025.

Request Sample Copy of this Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/242

As bone health significantly deteriorates with age, this would lead to a large number of falls and resultant fractures. Statistics released by the National Osteoporosis Foundation further revealed that 1.3 million hip fractures were report worldwide in 1990, which is expected to increase by 4.5 million by 2050. This inadvertently will boost growth of the bone glue market. According to Medanta Medicity—a major multi-specialty hospital based in India—Indians are found to have 15% lower bone density which puts Indians at a greater risk of broken bones compared to Caucasians.

The global bone glue market was valued at US$ 1,648.3 million in 2015 and is expected to witness a CAGR of 6.3% during the forecast period (2016 – 2024).

Naturally produced bone glue from animals hits the bone glue market

The growing prevalence of bone disorders and ageing population are the important aspects for the significant growth in bone glue market in Europe. Growing number of arthroplasty procedures and the consequent rise in demand for newer bone glues across various countries in Europe would further fuel growth of bone glue market in the region. However, stringent regulations in US such as, institutions and universities who use animals for research purpose should be licensed and or registered with the U.S.

Department of Agriculture and facilities, regulated animals must be inspected yearly by USDA’s Animal and Plant Health Inspection Service, has hit the bone glue market by inhibiting the production of natural glue obtained from animals. Non-animal substitutes i.e. synthetic glue are relatively more expensive and can also lead to compatibility issues. Difficulties such as the irritation caused by the cement to the surrounding skin, over prolong application, breakdown of the cement can cause the artificial joint to come loose, breakage of cement in bits are associated with cemented arthroplasty is the one of the main concerns which hamper the growth of the bone glue market.

Bone cement implantation syndrome is most prominent in patients undergoing hip fracture treatment

Bone glue is a basic product needed in any minor fractures and also act as beneficial supplements for musculoskeletal tissue suture repair. There are various other options such as bone cement and bone surgery to treat multiple fractures. A study was conducted by various medical institutes and university hospitals in 2014, with a patient pool of around 1,016 patients who underwent cemented hemiarthroplasty at some point in their life. A common symptom called bone cement implantation syndrome was observed in people suffering from hip fractures and the incidence rate was reported to be between 25% and 30%.

Ask for customization @ https://www.coherentmarketinsights.com/insight/request-customization/242

Severe bone cement implantation syndrome was observed in 5–7% of patients in the study group. Independent preoperative threat issues for occurrence of bone cement implantation syndrome were irregularities in overall health conducted by the universities, i.e. ASA scores, COPD, and medication with diuretics and warfarin. In cemented total hip arthroplasty, fatalities were pegged at 0.11% and the death occurred during the time of cementation. Considering all these factors, companies have developed bone glue products. The increased usage of bone glue in such cases would boost growth of the bone glue market.

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Bone Glue Market Industry Forecast till 2024 here

News-ID: 1183022 • Views:

More Releases from Coherent Market Insights

Light Therapy Market Expected to Expand at a Steady 2024-2031 | Verilux, Inc., Northern Light Technology, TheraLight, LLC, Zepter International
Light Therapy Market Expected to Expand at a Steady 2024-2031 | Verilux, Inc., N …
Latest Report, titled "Light Therapy Market" Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2031, by Coherent Market Insights offers a comprehensive analysis of the industry, which comprises insights on the market analysis. The report provides an in-depth overview within a particular industry or across diverse sectors. This comprehensive report employs a combination of quantitative and qualitative analyses, predicting trends across the timeline from 2024 to 2031. Factors under consideration
Health Supplementary Food OEM and ODM Market Growth in Future Scope 2024-2031 | Cosmax Inc., Kolmar Korea, Japan Supplement Foods Co.
Health Supplementary Food OEM and ODM Market Growth in Future Scope 2024-2031 | …
Coherent Market Insights introduces new research on the Health Supplementary Food OEM and ODM Market covering the micro level of analysis by competitors and key business segments (2024-2031). This report study encompasses a thorough examination of diverse segments, including opportunities, size, development, innovation, sales, and overall growth trajectory of major players. The research is carried out on primary and secondary statistical sources, providing a blend of qualitative and quantitative insights.
North America And Europe Minimally Invasive Prostate Cancer Surgery Market Expected to Expand at a Steady 2024-2031 | AngioDynamics, Profound Medical, Medtronic, Johnson & Johnson Services, Inc
North America And Europe Minimally Invasive Prostate Cancer Surgery Market Expec …
Latest Report, titled "North America And Europe Minimally Invasive Prostate Cancer Surgery Market" Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2031, by Coherent Market Insights offers a comprehensive analysis of the industry, which comprises insights on the market analysis. The report provides an in-depth overview within a particular industry or across diverse sectors. This comprehensive report employs a combination of quantitative and qualitative analyses, predicting trends across the timeline
Chemotherapy Induced Thrombocytopenia Therapeutics Market Expected to Expand at a Steady 2024-2031 | Amgen, Inc., Novartis AG, Pfizer Inc., Swedish Orphan Biovitrum AB
Chemotherapy Induced Thrombocytopenia Therapeutics Market Expected to Expand at …
Latest Report, titled "Chemotherapy Induced Thrombocytopenia Therapeutics Market" Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2031, by Coherent Market Insights offers a comprehensive analysis of the industry, which comprises insights on the market analysis. The report provides an in-depth overview within a particular industry or across diverse sectors. This comprehensive report employs a combination of quantitative and qualitative analyses, predicting trends across the timeline from 2024 to 2031. Factors

All 5 Releases


More Releases for Osteoporosis

Osteoporosis Drugs Market: Demand for Osteoporosis Drugs High Among Geriatric Po …
The global osteoporosis drugs market is analyzed in a report by Transparency Market Research (TMR). The market is expected to grow due to the increasing geriatric population across the globe. The market for osteoporosis drugs is considered semi-consolidated as a handful of players hold a larger share in the market. As per the analysis, Novartis International AG, Eli Lilly and Company, Merck & Co. Inc., Pfizer Inc., and Amgen Inc.
Osteoporosis Drugs Market : Rising prevalence of osteoporosis and aging populati …
The global osteoporosis drugs market is analyzed in a report by Transparency Market Research (TMR). The market is expected to grow due to the increasing geriatric population across the globe. The market for osteoporosis drugs is considered semi-consolidated as a handful of players hold a larger share in the market. As per the analysis, Novartis International AG, Eli Lilly and Company, Merck & Co. Inc., Pfizer Inc., and Amgen Inc.
Bone Densitometry Scan for Osteoporosis & Osteopenia
Global Bone Densitometers Market: Snapshot Of late, the global bone densitometers market has been registering a phenomenal increase in its size and valuation. The significant rise in the pool of patients suffering from arthritis and vitamin D deficiency, supported by the surge in the geriatric population across the world, have influenced this market substantially. The increasing prevalence of osteoporosis in post-menopausal women is also contributing considerably to the growth of
2022 Osteoporosis Drugs Market Analysis & Forecast
Global Osteoporosis Drugs Market Information, by drug class (Bisphosphonates, Calcitonins, Selective Estrogen Receptor Modulators (SERMs), Parathyroid Hormone (PTH) and Others), by route of administration (oral, injectable and others) and by gender (male and female) - Forecast to 2022 The Global Osteoporosis Market to reach 14,300 million by 2022, growing with a CAGR of 4.7%. Osteoporosis is weakening of bones due to lower bone mass resulting in and micro-architectural deterioration of bone
Datamonitor Healthcare Osteoporosis KOL Interviews
ReportsWorldwide has announced the addition of a new report title Datamonitor Healthcare Osteoporosis KOL Interviews to its growing collection of premium market research reports. For a Detailed description and table of contents of this report please click here: https://www.reportsworldwide.com/report/datamonitor-healthcare-osteoporosis-kol-interviews February 03, 2017 Datamonitor Healthcare interviewed an endocrinologist based in the US and a rheumatologist based in the UK to gauge their views on current treatment options, late stage clinical candidates, treatment challenges
Global Postmenopausal Osteoporosis Therapeutics Market
The Postmenopausal Osteoporosis Therapeutics Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. Osteoporosis is an orthopedic condition where the bone density and bone mass decreases and eventually increases the risk of bone fracture. Osteoporosis is one of the most common age related